Related Experiment Videos
The evolving role of submucosal injectables for treating internal sphincteric deficiency
G M Ghoniem1, R Elsergany, V Lewis
1Department of Urology, Tulane University Medical Center School of Medicine, New Orleans, LA, USA.
Urologic Nursing
|December 29, 1998
Summary
Injectable materials offer an effective outpatient treatment for stress urinary incontinence (SUI) with minimal risks and rapid recovery. However, the optimal bulking agent for SUI injection therapy remains undetermined.
Area of Science:
- Urology
- Minimally Invasive Surgery
Background:
- Stress urinary incontinence (SUI) is a common condition affecting quality of life.
- Various injectable bulking agents are used for SUI treatment.
Purpose of the Study:
- To review the use of injectable materials for SUI.
- To compare the advantages and disadvantages of different bulking agents.
Main Methods:
- Review of existing literature on injectable bulking agents for SUI.
- Analysis of procedural aspects, including anesthesia and patient selection.
- Discussion of postoperative care and recovery.
Main Results:
- Injectable materials allow for outpatient procedures under local anesthesia, avoiding risks of open surgery.
- Teflon requires general anesthesia; other agents are suitable for local anesthesia.
- Contraindications include acute cystitis, urolithiasis, or infection.
- Procedures are faster, less costly, with rapid recovery (return to activity within 48 hours).
Conclusions:
- Injection therapy is a viable option for SUI treatment.
- The most effective bulking substance for SUI has yet to be determined.